Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
13.30
-0.30 (-2.21%)
At close: May 1, 2026, 4:00 PM EDT
13.39
+0.09 (0.68%)
After-hours: May 1, 2026, 7:54 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $830.68 million as of May 1, 2026. Its market cap has increased by 332.97% in one year.
Market Cap
830.68M
Enterprise Value
610.59M
1-Year Change
332.97%
Ranking
Category
Stock Price
$13.30
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $830.68M, a decrease of -62.35%. That is a compound annual growth rate of -17.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 830.68M | 55.46% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 876.98M |
| Alto Neuroscience | 874.22M |
| Janux Therapeutics | 872.33M |
| MeiraGTx Holdings | 870.96M |
| Theravance Biopharma | 864.31M |
| Bright Minds Biosciences | 861.94M |
| Arbutus Biopharma | 850.78M |
| ARS Pharmaceuticals | 849.98M |